Torsten Hoffmann

Torsten Hoffmann

Corporate Officer/Principal bij
American Chemical Society
59 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.

Actieve functies van Torsten Hoffmann

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal -

Eerdere bekende functies van Torsten Hoffmann

BedrijvenFunctieEinde
SILENCE THERAPEUTICS PLC Operationeel Directeur 21-06-2018
ZEALAND PHARMA A/S Hoofd Techniek/Wetenschap/O&O 01-01-2015
ROCHE HOLDING AG Corporate Officer/Principal 01-01-2015
ORYZON GENOMICS S.A. Hoofd Techniek/Wetenschap/O&O -
Corporate Officer/Principal -
Ervaring van Torsten Hoffmann in detail bekijken

Opleiding van Torsten Hoffmann

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

68

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

  1. Beurs
  2. Insiders
  3. Torsten Hoffmann